Literature DB >> 32460645

Successful use of Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricular support for acute respiratory distress syndrome in an adolescent with complex congenital heart disease.

Niranjan Vijayakumar1, Aditya Badheka1, Madhuradhar Chegondi1, Daniel Mclennan2.   

Abstract

Rescuing patients with the development of acute respiratory distress syndrome and right heart failure after left ventricular assist device placement remains a challenge in patients with congenital heart disease. TandemLife Protek Duo (TandemLife, Pittsburg, PA) is a double-lumen cannula introduced via the internal jugular vein that can provide veno-venous extra-corporeal membrane oxygenation and right heart support. To our knowledge, we report the first case of successfully using the TandemLife Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricle support in an adolescent male with an existing right ventricle-pulmonary artery conduit and the melody pulmonary valve who developed severe acute respiratory distress syndrome after the placement of left ventricular assist device. The stability of the cannula enabled minimal recirculation-related hypoxia events, early mobilization, and ambulation. Our patient was discharged home after lung recovery and currently awaiting a heart transplant.

Entities:  

Keywords:  Avalon; Protek Duo; acute respiratory distress syndrome; extra-corporeal membrane oxygenation; left ventricular assist device; melody valve; right ventricle support; right ventricular assist device; veno-venous extra-corporeal membrane oxygenation

Mesh:

Year:  2020        PMID: 32460645     DOI: 10.1177/0267659120923880

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  1 in total

1.  First-in-man successful use of the SPECTRUM percutaneous dual-stage right ventricle and right atrium to pulmonary artery ventricular assist device.

Authors:  Asad A Usman; Audrey E Spelde; Salim E Olia; Marisa Cevasco; Christian Bermudez; John Haddle; Michael Ibrahim; Wilson Szeto; William Vernick; Jacob Gutsche
Journal:  J Card Surg       Date:  2022-07-23       Impact factor: 1.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.